ClinicalTrials.gg
CompletedNCT03496688Updated Apr 12, 2018

Comparative Results of Six Biomaterials Used in Two-stage Maxillary Sinus

An interventional study of Sinus floor augmentation in Atrophy, Jaw, Edentulous, Partially and Sinus Floor Augmentation, sponsored by University of Roma La Sapienza. Completed. Open to participants aged 33 Years to 70 Years. Per ClinicalTrials.gov, last updated 2018-04-12.

Primary conditionJaw, Edentulous, PartiallyRegistry: AtrophyReclassifiedWhy we changed it
Registry
Atrophy — the first condition term the registry derived for this study.
ClinicalTrials.gg
Jaw, Edentulous, Partially
Why
  1. Atrophy is a broad heading, used only when no more specific condition is named.
  2. The study's listed conditions name Jaw, Edentulous, Partially.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by University of Roma La Sapienza · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 3 years 2 months after the study started (first participant enrolled Jan 2015, registered Mar 2018).
Phase
Not applicable
Study type
Interventional
Enrollment
6
Allocation
Randomized
Ages
33 Years to 70 Years
Sex
All
01

Study summary

Objectives: The aim of the study was to compare histological and histomorphometric results of six bone substitute materials used as graft in two-stage maxillary sinus augmentation model, after 6-month-healing.

Read the detailed description

Materials and Methods:

A two-stage sinus augmentation was carried out in six patients using mineralized solvent-dehydrated bone allograft (MCBA), freeze-dried mineralized bone allograft (FDBA), anor-ganic bovine bone (ABB), equine-derived bone (EB); synthetic micromacroporous biphasic calcium-phosphate block consisting of 70% beta-tricalcium phosphate and 30% hydroxyap-atite (HA-β-TCP 30/70), or bioapatite-collagen (BC).

02

Conditions studied

  • Atrophy
  • Jaw, Edentulous, Partially
  • Sinus Floor Augmentation
  • Bone Substitutes
  • Bone Regeneration

Browse trials for

Keywords

  • Sinus floor augmentation
  • Bone regeneration
  • Histology
  • Biocompatible materials
  • Bone transplantation
03

In context

Jaw, Edentulous, Partially Reclassified

76 studies on the registry are indexed under Jaw, Edentulous, Partially; 7 are open to participants now.

This study's enrollment of 6 is below the median of 38 across 67 interventional studies indexed under Jaw, Edentulous, Partially.

Browse Jaw, Edentulous, Partially studies →

Lead sponsor

University of Roma La Sapienza is the lead sponsor of 398 studies on the registry; 56 are open to participants now.

Compared within Jaw, Edentulous, Partially, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Atrophy. The counts are of registry records indexed under each term, refreshed daily. How we classify →

04

Who can participate

Ages eligible
33 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Inclusion Criteria: patients healthy, absence of systemic pathologies ( I), non-smokers, good oral hygiene, not pregnant or lactating, absence of painful symptoms and associated inflammatory or osteolytic pathologies, maxillary partial edentulism involving the premolar/molar areas, residual bone height between the sinus floor and alveolar ridge ranging from 2 to 4 mm, as measured on computerized tomography (CT) scan.

-

Exclusion Criteria:

-

Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
6 participants (actual)

Study arms

  • Active comparator
    bone substitute material MCBA

    Sinus floor augmentation: a bony window was created along the lateral wall of the sinus, the sinus membrane was carefully elevated and the created space was augmented using mineralized sol-vent-dehydrated bone allograft material.

    Procedure: Sinus floor augmentation

  • Active comparator
    bone substitute material FDBA

    Sinus floor augmentation: a bony window was created along the lateral wall of the sinus, the sinus membrane was carefully elevated and the created space was augmented using freeze-dried mineralized bone allograft material.

    Procedure: Sinus floor augmentation

  • Active comparator
    bone substitute material ABB

    Sinus floor augmentation: a bony window was created along the lateral wall of the sinus, the sinus membrane was carefully elevated and the created space was augmented using anorganic bovine bone material.

    Procedure: Sinus floor augmentation

  • Active comparator
    bone substitute material EB

    Sinus floor augmentation: a bony window was created along the lateral wall of the sinus, the sinus membrane was carefully elevated and the created space was augmented using equine-derived bone material.

    Procedure: Sinus floor augmentation

  • Active comparator
    bone substitute material HA-β-TCP 30/70

    Sinus floor augmentation: a bony window was created along the lateral wall of the sinus, the sinus membrane was carefully elevated and the created space was augmented using synthetic micromacroporous bi-phasic calcium-phosphate block consisting of 70% beta-tricalcium phosphate and 30% hy-droxyapatite material.

    Procedure: Sinus floor augmentation

  • Active comparator
    bone substitute material BC

    Sinus floor augmentation: a bony window was created along the lateral wall of the sinus, the sinus membrane was carefully elevated and the created space was augmented using bioapatite-collagen material.

    Procedure: Sinus floor augmentation

Interventions

  • ProcedureSinus floor augmentation
06

What researchers measure

Primary outcomes

  1. to perform biopsies from each six augmented site using to compare, histologically and histomorphometrically, the percentages of newly formed bone, residual grafted material, and marrow spaces.

    After 6 months clinical and radiographic examinations were undertaken and each patient was reappointed for biopsy at the time of implant placement in the same location. Under local anesthesia, a full thickness flap was raised, a biopsy was performed using a 3.5 mm tre-phine bur under sterile saline solution irrigation, guided by the radiographic/surgical template in the selected implant site. A total of six bone samples was retrieved from the occlusal aspect to the alveolar crest, one from each augmented site to compare histologically and histomorphometrically the different materials.

    Time frame: 6 month-healing after surgery

07

Study locations

No study locations are listed for this record.

08

References and documents

Publications

  • La Monaca G, Iezzi G, Cristalli MP, Pranno N, Sfasciotti GL, Vozza I. Comparative Histological and Histomorphometric Results of Six Biomaterials Used in Two-Stage Maxillary Sinus Augmentation Model after 6-Month Healing. Biomed Res Int. 2018 Jun 27;2018:9430989. doi: 10.1155/2018/9430989. eCollection 2018. PubMed 30050947 ↗

Individual participant data

Plan to share: Undecided

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jan 2015 to primary completion in Jan 2016, 11 months.

Of 34 interventional studies with no phase under Jaw, Edentulous, Partially, half reached primary completion within 35 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 61. This study's 11 months is below that.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 29, 2018
First posted
Apr 12, 2018
StartActual
Jan 12, 2015
Primary completionActual
Jan 4, 2016
CompletionActual
Sep 11, 2017
Last update
Apr 12, 2018
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 12, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03496688
Responsible party
Maria Paola Cristalli (DDS PhD, Clinical Professor, University of Roma La Sapienza) — Principal investigator
First posted
Apr 12, 2018
Start date
Jan 12, 2015
Primary completion
Jan 4, 2016
Completion
Sep 11, 2017
Last update
Apr 12, 2018

Study contacts

Maria Paola Cristalli, DDS
principal investigator · University of Roma La Sapienza

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion